Ligand-Selective Potentiation of Rat Mineralocorticoid Receptor Activation Function 1 by a CBP-Containing Histone Acetyltransferase Complex

REFERENCES

• Agarwal, M. K. 1994. Perspectives in receptor-mediated mineralocorticoid hormone action. Pharmacol. Rev. 46: 67–87.
   PubMedGoogle Scholar
• Anderson, S. F., B. P. Schlegel, T. Nakajima, E. S. Wolpin, and J. D. Parvin. 1998. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat. Genet. 19: 254–256.
   PubMed Web of Science ®Google Scholar
• Anzick, S. L., J. Kononen, R. L. Walker, D. O. Azorsa, M. M. Tanner, X. Y. Guan, G. Sauter, O. P. Kallioniemi, J. M. Trent, and P. S. Meltzer. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965–968.
   PubMed Web of Science ®Google Scholar
• Aratani, S., R. Fujii, T. Oishi, H. Fujita, T. Amano, T. Ohshima, M. Hagiwara, A. Fukamizu, and T. Nakajima. 2001. Dual roles of RNA helicase A in CREB-dependent transcription. Mol. Cell. Biol. 21: 4460–4469.
   PubMed Web of Science ®Google Scholar
• Berger, S., M. Bleich, W. Schmid, T. J. Cole, J. Peters, H. Watanabe, W. Kriz, R. Warth, R. Greger, and G. Schutz. 1998. Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc. Natl. Acad. Sci. USA 95: 9424–9429.
   PubMedGoogle Scholar
• Brownell, J. E., and C. D. Allis. 1995. An activity gel assay detects a single, catalytically active histone acetyltransferase subunit in Tetrahymena macronuclei. Proc. Natl. Acad. Sci. USA 92: 6364–6368.
   PubMed Web of Science ®Google Scholar
• Brzozowski, A. M., A. C. Pike, Z. Dauter, R. E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G. L. Greene, J. A. Gustafsson, and M. Carlquist. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753–758.
   PubMed Web of Science ®Google Scholar
• Endoh, H., K. Maruyama, Y. Masuhiro, Y. Kobayashi, M. Goto, H. Tai, J. Yanagisawa, D. Metzger, S. Hashimoto, and S. Kato. 1999. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol. Cell. Biol. 19: 5363–5372.
   PubMed Web of Science ®Google Scholar
• Fagart, J., J. M. Wurtz, A. Souque, C. Hellal-Levy, D. Moras, and M. E. Rafestin-Oblin. 1998. Antagonism in the human mineralocorticoid receptor. EMBO J. 17: 3317–3325.
   PubMed Web of Science ®Google Scholar
• Farman, N. 1999. Molecular and cellular determinants of mineralocorticoid selectivity. Curr. Opin. Nephrol. Hypertens. 8: 45–51.
   PubMed Web of Science ®Google Scholar
• Freedman, L. P. 1999. Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97: 5–8.
   PubMed Web of Science ®Google Scholar
• Fujii, R., M. Okamoto, S. Aratani, T. Oishi, T. Ohshima, K. Taira, M. Baba, A. Fukamizu, and T. Nakajima. 2001. A role of RNA helicase A in cis-acting transactivation response element-mediated transcriptional regulation of human immunodeficiency virus type 1. J. Biol. Chem. 276: 5445–5451.
   PubMedGoogle Scholar
• Funder, J., and K. Myles. 1996. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. Endocrinology 137: 5264–5268.
   PubMed Web of Science ®Google Scholar
• Funder, J. W. 1998. Aldosterone action: fact, failure and the future. Clin. Exp. Pharmacol. Physiol. Suppl. 25: S47–S50.
   PubMedGoogle Scholar
• Funder, J. W., P. T. Pearce, R. Smith, and A. I. Smith. 1988. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583–585.
   PubMed Web of Science ®Google Scholar
• Fuse, H., H. Kitagawa, and S. Kato. 2000. Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Mol. Endocrinol. 14: 889–899.
   PubMedGoogle Scholar
• Gass, P., O. Kretz, D. P. Wolfer, S. Berger, F. Tronche, H. M. Reichardt, C. Kellendonk, H. P. Lipp, W. Schmid, and G. Schutz. 2000. Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Rep. 1: 447–451.
   PubMed Web of Science ®Google Scholar
• Gill, R. K., L. M. Atkins, B. W. Hollis, and N. H. Bell. 1998. Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1. Mol. Endocrinol. 12: 57–65.
   PubMedGoogle Scholar
• Glass, C. K., and M. G. Rosenfeld. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14: 121–141.
   PubMed Web of Science ®Google Scholar
• Gomez-Sanchez, E. P., C. M. Fort, and C. E. Gomez-Sanchez. 1990. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am. J. Physiol. 258: E482–E484.
   PubMedGoogle Scholar
• Gomez-Sanchez, E. P., M. T. Venkataraman, D. Thwaites, and C. Fort. 1990. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am. J. Physiol. 258: E649–E653.
   PubMed Web of Science ®Google Scholar
• Govindan, M. V., and N. Warriar. 1998. Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. J. Biol. Chem. 273: 24439–24447.
   PubMedGoogle Scholar
• Gu, W., S. Malik, M. Ito, C. X. Yuan, J. D. Fondell, X. Zhang, E. Martinez, J. Qin, and R. G. Roeder. 1999. A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation. Mol. Cell 3: 97–108.
   PubMed Web of Science ®Google Scholar
• Hellman, U., C. Wernstedt, J. Gonez, and C. H. Heldin. 1995. Improvement of an “in-gel” digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. Anal. Biochem. 224: 451–455.
   PubMed Web of Science ®Google Scholar
• Hittelman, A. B., D. Burakov, J. A. Iniguez-Lluhi, L. P. Freedman, and M. J. Garabedian. 1999. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J. 18: 5380–5388.
   PubMed Web of Science ®Google Scholar
• Jausons-Loffreda, N., C. Chabret, and M. Pons. 1994. Role of the A/B region of the human mineralocorticoid receptor in aldosterone response selectivity. Biochem. Biophys. Res. Commun. 205: 1610–1616.
   PubMedGoogle Scholar
• Kobayashi, T., and S. Kato. 2000. Hallucination of soliloquy: speaking component and hearing component of schizophrenic hallucinations. Psychiatry Clin. Neurosci. 54: 531–536.
   PubMed Web of Science ®Google Scholar
• Kodera, Y., K. Takeyama, A. Murayama, M. Suzawa, Y. Masuhiro, and S. Kato. 2000. Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators. J. Biol. Chem. 275: 33201–33204.
   PubMed Web of Science ®Google Scholar
• Kolla, V., N. M. Robertson, and G. Litwack. 1999. Identification of a mineralocorticoid/glucocorticoid response element in the human Na/K ATPase α1 gene promoter. Biochem. Biophys. Res. Commun. 266: 5–14.
   PubMed Web of Science ®Google Scholar
• Lanz, R. B., N. J. McKenna, S. A. Onate, U. Albrecht, J. Wong, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1999. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97: 17–27.
   PubMed Web of Science ®Google Scholar
• Lees, J. A., S. E. Fawell, and M. G. Parker. 1989. Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res. 17: 5477–5488.
   PubMed Web of Science ®Google Scholar
• Le Menuet, D., R. Isnard, M. Bichara, S. Viengchareun, M. Muffat-Joly, F. Walker, M. C. Zennaro, and M. Lombes. 2001. Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor. J. Biol. Chem. 276: 38911–38920.
   PubMed Web of Science ®Google Scholar
• Lim-Tio, S. S., and P. J. Fuller. 1998. Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors. Endocrinology 139: 1653–1661.
   PubMedGoogle Scholar
• Lombes, M., S. Kenouch, A. Souque, N. Farman, and M. E. Rafestin-Oblin. 1994. The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11β-hydroxysteroid dehydrogenase. Endocrinology 135: 834–840.
   PubMedGoogle Scholar
• Mick, V. E., O. A. Itani, R. W. Loftus, R. F. Husted, T. J. Schmidt, and C. P. Thomas. 2001. The alpha-subunit of the epithelial sodium channel is an aldosterone-induced transcript in mammalian collecting ducts, and this transcriptional response is mediated via distinct cis-elements in the 5′-flanking region of the gene. Mol. Endocrinol. 15: 575–588.
   PubMedGoogle Scholar
• Nakajima, T., C. Uchida, S. F. Anderson, C. G. Lee, J. Hurwitz, J. D. Parvin, and M. Montminy. 1997. RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90: 1107–1112.
   PubMedGoogle Scholar
• Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953–959.
   PubMed Web of Science ®Google Scholar
• Onate, S. A., S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354–1357.
   PubMed Web of Science ®Google Scholar
• Pellizzoni, L., B. Charroux, J. Rappsilber, M. Mann, and G. Dreyfuss. 2001. A functional interaction between the survival motor neuron complex and RNA polymerase II. J. Cell Biol. 152: 75–85.
   PubMed Web of Science ®Google Scholar
• Pitt, B., F. Zannad, W. J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes, et al. 1999. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341: 709–717.
   PubMed Web of Science ®Google Scholar
• Rachez, C., B. D. Lemon, Z. Suldan, V. Bromleigh, M. Gamble, A. M. Naar, H. Erdjument-Bromage, P. Tempst, and L. P. Freedman. 1999. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398: 824–828.
   PubMed Web of Science ®Google Scholar
• Rachez, C., Z. Suldan, J. Ward, C. P. Chang, D. Burakov, H. Erdjument-Bromage, P. Tempst, and L. P. Freedman. 1998. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev. 12: 1787–1800.
   PubMedGoogle Scholar
• Rosenfeld, J., J. Capdevielle, J. C. Guillemot, and P. Ferrara. 1992. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal. Biochem. 203: 173–179.
   PubMed Web of Science ®Google Scholar
• Shao, D., S. M. Rangwala, S. T. Bailey, S. L. Krakow, M. J. Reginato, and M. A. Lazar. 1998. Interdomain communication regulating ligand binding by PPAR-γ. Nature 396: 377–380.
   PubMed Web of Science ®Google Scholar
• Shevchenko, A., M. Wilm, O. Vorm, and M. Mann. 1996. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 68: 850–858.
   PubMed Web of Science ®Google Scholar
• Shull, M. M., D. G. Pugh, and J. B. Lingrel. 1990. The human Na, K-ATPase α1 gene: characterization of the 5′-flanking region and identification of a restriction fragment length polymorphism. Genomics 6: 451–460.
   PubMed Web of Science ®Google Scholar
• Takeyama, K., Y. Masuhiro, H. Fuse, H. Endoh, A. Murayama, S. Kitanaka, M. Suzawa, J. Yanagisawa, and S. Kato. 1999. Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog. Mol. Cell. Biol. 19: 1049–1055.
   PubMed Web of Science ®Google Scholar
• Tanner, N. K., and P. Linder. 2001. DExD/H box RNA helicases: from generic motors to specific dissociation functions. Mol. Cell 8: 251–262.
   PubMed Web of Science ®Google Scholar
• Tora, L., J. White, C. Brou, D. Tasset, N. Webster, E. Scheer, and P. Chambon. 1989. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59: 477–487.
   PubMed Web of Science ®Google Scholar
• Torchia, J., D. W. Rose, J. Inostroza, Y. Kamei, S. Westin, C. K. Glass, and M. G. Rosenfeld. 1997. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387: 677–684.
   PubMed Web of Science ®Google Scholar
• Trapp, T., and F. Holsboer. 1995. Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping. Biochem. Biophys. Res. Commun. 215: 286–291.
   PubMed Web of Science ®Google Scholar
• Tsai, S. Y., M. J. Tsai, and B. W. O'Malley. 1989. Cooperative binding of steroid hormone receptors contributes to transcriptional synergism at target enhancer elements. Cell 57: 443–448.
   PubMedGoogle Scholar
• Voegel, J. J., M. J. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15: 3667–3675.
   PubMed Web of Science ®Google Scholar
• Watanabe, M., J. Yanagisawa, H. Kitagawa, K. Takeyama, S. Ogawa, Y. Arao, M. Suzawa, Y. Kobayashi, T. Yano, H. Yoshikawa, Y. Masuhiro, and S. Kato. 2001. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J. 20: 1341–1352.
   PubMedGoogle Scholar
• Wu, X., H. Li, and J. D. Chen. 2001. The human homologue of the yeast DNA repair and TFIIH regulator MMS19 is an AF-1-specific coactivator of estrogen receptor. J. Biol. Chem. 276: 23962–23968.
   PubMedGoogle Scholar
• Yanagisawa, J., Y. Yanagi, Y. Masuhiro, M. Suzawa, M. Watanabe, K. Kashiwagi, T. Toriyabe, M. Kawabata, K. Miyazono, and S. Kato. 1999. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283: 1317–1321.
   PubMed Web of Science ®Google Scholar
• Young, M. 1995. Adrenal steroids and cardiac fibrosis. Steroids 60: 133–136.
   PubMedGoogle Scholar
• Young, M., G. Head, and J. Funder. 1995. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am. J. Physiol. 269: E657–E662.
   Google Scholar
• Young, M. J., and J. W. Funder. 1996. Mineralocorticoids, salt, hypertension: effects on the heart. Steroids 61: 233–235.
   PubMedGoogle Scholar
• Zennaro, M. C., D. Le Menuet, S. Viengchareun, F. Walker, D. Ricquier, and M. Lombes. 1998. Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. J. Clin. Investig. 101: 1254–1260.
   PubMed Web of Science ®Google Scholar
• Zennaro, M. C., A. Souque, S. Viengchareun, E. Poisson, M. Lombes, C. Rachez, and L. P. Freedman. 2001. A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Mol. Endocrinol. 15: 1586–1598.
   PubMedGoogle Scholar